| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |